HIS-Q Trademark

Trademark Overview

On Monday, January 12, 2015, a trademark application was filed for HIS-Q with the United States Patent and Trademark Office. The USPTO has given the HIS-Q trademark a serial number of 86501002. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, February 23, 2024. This trademark is owned by Unimed Pharmaceuticals LLC. The HIS-Q trademark is filed in the Paper & Printed Material Products category with the following description:

patient-reported outcome questionnaire measuring the symptoms and impacts of low testosterone
his-q

General Information

Serial Number86501002
Word MarkHIS-Q
Filing DateMonday, January 12, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, February 23, 2024
Registration Number5261523
Registration DateTuesday, August 8, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 9, 2015

Trademark Statements

Goods and Servicespatient-reported outcome questionnaire measuring the symptoms and impacts of low testosterone

Classification Information

International Class016 - Paper, cardboard and goods made from these materials, not included in other classes; printed matter; bookbinding material; photographs; stationery; adhesives for stationery or household purposes; artists' materials; paint brushes; typewriters and office requisites (except furniture); instructional and teaching material (except apparatus); plastic materials for packaging (not included in other classes); printers' type; printing blocks.
US Class Codes002, 005, 022, 023, 029, 037, 038, 050
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 23, 2024
Primary Code016
First Use Anywhere DateThursday, September 3, 2015
First Use In Commerce DateThursday, September 3, 2015

Trademark Owner History

Party NameUnimed Pharmaceuticals LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressNorth Chicago, IL 60064
Party NameUnimed Pharmaceuticals LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNorth Chicago, IL 60064
Party NameUnimed Pharmaceuticals LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNorth Chicago, IL 60064

Trademark Events

Event DateEvent Description
Friday, February 23, 2024CANCELLED SEC. 8 (6-YR)
Monday, August 8, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, August 8, 2017REGISTERED-PRINCIPAL REGISTER
Saturday, July 1, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, June 30, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, June 30, 2017ATTORNEY REVIEW COMPLETED
Wednesday, June 28, 2017ASSIGNED TO LIE
Tuesday, May 30, 2017TEAS POST PUBLICATION AMENDMENT RECEIVED
Sunday, April 23, 2017ASSIGNED TO EXAMINER
Wednesday, March 29, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 29, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 28, 2017ASSIGNED TO LIE
Monday, March 13, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 13, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 13, 2016NON-FINAL ACTION E-MAILED
Tuesday, September 13, 2016SU - NON-FINAL ACTION - WRITTEN
Tuesday, August 23, 2016STATEMENT OF USE PROCESSING COMPLETE
Wednesday, July 27, 2016USE AMENDMENT FILED
Friday, August 19, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 27, 2016TEAS STATEMENT OF USE RECEIVED
Friday, February 5, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 3, 2016SOU EXTENSION 1 GRANTED
Wednesday, February 3, 2016SOU EXTENSION 1 FILED
Wednesday, February 3, 2016SOU TEAS EXTENSION RECEIVED
Tuesday, August 4, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 9, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 9, 2015PUBLISHED FOR OPPOSITION
Wednesday, May 20, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, April 30, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 16, 2015ASSIGNED TO EXAMINER
Thursday, January 22, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 15, 2015NEW APPLICATION ENTERED

Related Keywords

symptoms impacts testosterone measuring questionnaire reported outcome patient